 | Pfizer's Pneumococcal Vaccine Gets Breakthrough Therapy Status
finance.yahoo.com - September 21 at 3:28 PM |
| Eli Lilly Prices Animal Health Unit IPO at $24 Per Share
finance.yahoo.com - September 20 at 3:34 PM |
 | Merck or Pfizer: Which is the Better Large-Cap Pharma Stock?
www.zacks.com - September 20 at 11:06 AM |
 | FDA grants Breakthrough Therapy designation to Pfizer's PF-06482077
seekingalpha.com - September 20 at 11:06 AM |
 | Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years ...
www.businesswire.com - September 20 at 11:06 AM |
| Pharma Stocks: GlaxoSmithKline’s Revenue Trend and 2018 Estimates
finance.yahoo.com - September 20 at 11:06 AM |
| Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
finance.yahoo.com - September 20 at 11:06 AM |
| [$$] Companies' Brexit Challenge: Preparing for the Unknown
finance.yahoo.com - September 20 at 11:06 AM |
| Pharma Stocks: Pfizer’s Revenue Trend and 2018 Estimates
finance.yahoo.com - September 19 at 3:37 PM |
| Pfizer And Conatus: Emricasan And NASH
seekingalpha.com - September 19 at 10:17 AM |
 | Pfizer Inc. (PFE) Short Interest Update
www.americanbankingnews.com - September 19 at 1:38 AM |
| Health care ETF surges toward record in a broad sector rally
finance.yahoo.com - September 18 at 3:42 PM |
| New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting
finance.yahoo.com - September 18 at 3:42 PM |
 | Pfizer Reports Addl Analyses From Tafamidis Phase 3 ATTR-ACT Study
www.nasdaq.com - September 18 at 10:47 AM |
| Watson Health Still the Key Driver for IBM’s AI Business
finance.yahoo.com - September 18 at 10:47 AM |
| Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts
finance.yahoo.com - September 18 at 10:47 AM |
| A Review of Pharma Stocks’ EPS Growth Rates
finance.yahoo.com - September 18 at 10:47 AM |
| How Pharmaceutical ETFs Have Performed in 2018
finance.yahoo.com - September 17 at 3:35 PM |
| A Look at the Market Caps of the Pharma Stocks under Review
finance.yahoo.com - September 17 at 3:35 PM |
| This cancer-fighting biotech sped from startup to IPO filing in 10 months
finance.yahoo.com - September 17 at 10:30 AM |
| Pfizer Inc. (PFE) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 17 at 4:52 AM |
| Pfizer's JAK inhibitors show positive effect in mid-stage alopecia areata study
seekingalpha.com - September 16 at 10:11 AM |
| Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - September 15 at 10:17 AM |
| Pfizer Reports Positive Phase 2 Data Of JAK Inhibitors In Alopecia Areata
www.nasdaq.com - September 15 at 10:17 AM |
| How Spark Therapeutics Is Positioned in 2018
finance.yahoo.com - September 14 at 3:36 PM |
| Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus
finance.yahoo.com - September 14 at 3:36 PM |
| Pfizer (PFE) Given a $45.00 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - September 13 at 10:33 AM |
| Pfizer (PFE) PT Set at $45.00 by Cantor Fitzgerald
www.americanbankingnews.com - September 13 at 10:32 AM |
| JNJ Stock Up 7% in the Past Month: What Drove the Bulls?
finance.yahoo.com - September 13 at 10:27 AM |
| Your Cancer Highlight: Pfizer Gets Ready For An Imminent Lung Cancer Approval
seekingalpha.com - September 12 at 3:34 PM |
| Pfizer's Drug Combo Betters Survival in Kidney Cancer Study
www.zacks.com - September 12 at 10:02 AM |
| Pfizer to suspend operations at NC injectables plant ahead of Hurricane Florence
seekingalpha.com - September 11 at 3:34 PM |
| Merck, Pfizer Report Positive Top-line Results From Phase III JAVELIN 101 Study
www.nasdaq.com - September 11 at 10:54 AM |
 | A Look At Pfizer's Business And Outlook
www.forbes.com - September 10 at 3:13 PM |
| Johnson & Johnson Vs. Pfizer: You Can't Go Wrong With Either Stock
seekingalpha.com - September 10 at 11:06 AM |
| The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson
finance.yahoo.com - September 10 at 11:06 AM |
| Pfizer (PFE) PT Set at $42.00 by JPMorgan Chase & Co.
www.americanbankingnews.com - September 10 at 10:44 AM |
| Pfizer (PFE) Price Target Raised to $47.00
www.americanbankingnews.com - September 7 at 10:27 AM |
| Your first trade for Friday, Sept 7
finance.yahoo.com - September 7 at 10:19 AM |
| Pfizer Inc. (PFE) Expected to Announce Quarterly Sales of $13.51 Billion
www.americanbankingnews.com - September 7 at 3:56 AM |
| Pfizer’s PF-06651600 Receives a Breakthrough Therapy Designation
finance.yahoo.com - September 6 at 3:34 PM |
| Pfizer (PFE) Given a $40.00 Price Target by Credit Suisse Group Analysts
www.americanbankingnews.com - September 6 at 1:29 PM |
| Morgan Stanley Analysts Give Pfizer (PFE) a $45.00 Price Target
www.americanbankingnews.com - September 6 at 12:33 PM |
| Pfizer's Skin Disease Drug Gets Breakthrough Therapy Status
www.zacks.com - September 6 at 10:48 AM |
| Large Cap Pharma Stocks Staging a Comeback in Second Half
finance.yahoo.com - September 6 at 10:48 AM |
| Top Analyst Reports for Pfizer, Salesforce & ADP
www.zacks.com - September 5 at 3:37 PM |
| $0.75 Earnings Per Share Expected for Pfizer Inc. (PFE) This Quarter
www.americanbankingnews.com - September 5 at 12:19 PM |
| Pfizer Gets Breakthrough Therapy Designation From FDA For PF-06651600
www.nasdaq.com - September 5 at 10:40 AM |
| Pfizer receives Breakthrough Therapy designation for PF-06651600 for the treatment of patients with alopecia areata
seekingalpha.com - September 5 at 10:40 AM |
 | Pfizer (PFE) Gains FDA Breakthrough Therapy Designation for PF-06651600
www.streetinsider.com - September 5 at 10:40 AM |
